Gsk (GSK) Assets (2009 - 2026)
Gsk (GSK) posted quarterly Assets of $82.8 billion for Q2 2026, up 4.78% year-over-year from $79.1 billion in Q2 2025, and down 2.27% quarter-over-quarter from $84.8 billion in Q1 2026.
Gsk (GSK) Assets (2009 - 2026) Analysis & Trends
Gsk's Assets history runs 18 years deep, the most recent figure standing at $82.8 billion for Q2 2026.
- In Q2 2026, Assets rose 4.78% year-over-year to $82.8 billion; the TTM figure through Jun 2026 stood at $82.8 billion (up 4.78% YoY), while the FY2025 annual figure was $80.6 billion, up 6.02% from the prior year.
- Assets for Q2 2026 stood at $82.8 billion, down from $84.8 billion in the prior quarter.
- The five-year high for Assets was $112.1 billion in Q2 2022, with the low at $60.4 billion in Q1 2022.
- The 5-year median for Assets is $75.9 billion (2024), against an average of $77.6 billion.
- The sharpest annual moves came in 2022 and 2023: Assets tumbled 43.89% in 2022, then increased 17.89% in 2023.
- Gsk's Assets stood at $70.5 billion in 2022, then advanced by 3.81% to $73.2 billion in 2023, then increased by 4.21% to $76.3 billion in 2024, then climbed by 6.52% to $81.3 billion in 2025, then advanced by 1.89% to $82.8 billion in 2026.
- Business Quant data shows GSK's Assets at $82.8 billion in Q2 2026, $84.8 billion in Q1 2026, and $81.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 82.83 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 150.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 82.83 Bn |
| Mar 31, 2026 | 84.76 Bn |
| Dec 31, 2025 | 81.30 Bn |
| Sep 30, 2025 | 82.77 Bn |
| Jun 30, 2025 | 79.05 Bn |
| Mar 31, 2025 | 76.46 Bn |
| Dec 31, 2024 | 76.32 Bn |
| Sep 30, 2024 | 75.42 Bn |
| Jun 30, 2024 | 73.29 Bn |
| Mar 31, 2024 | 74.22 Bn |
| Dec 31, 2023 | 73.23 Bn |
| Sep 30, 2023 | 77.09 Bn |
| Jun 30, 2023 | 74.41 Bn |
| Mar 31, 2023 | 71.22 Bn |
| Dec 31, 2022 | 70.55 Bn |
| Sep 30, 2022 | 71.08 Bn |
| Jun 30, 2022 | 112.14 Bn |
| Mar 31, 2022 | 60.41 Bn |
| Dec 31, 2021 | 106.63 Bn |
| Sep 30, 2021 | 108.48 Bn |